Offshore
Video
Librarian Capital
Presented without comment https://t.co/xPb9mHh6Rl
tweet
Presented without comment https://t.co/xPb9mHh6Rl
Trump: “Residents are reporting the migrants are walking off with the town's geese. They've taken the geese. You know where the geese are? In the park, in the lake. And even walking off with their pets. My dog's been taken! My dog's gone! These people are the worst” https://t.co/bm3bbALqT9 tweet
Offshore
Photo
Stock Analysis Compilation
Baron Capital on Integer Holdings Corporation $ITGR US
Thesis: Integer Holdings is primed for rapid growth, leveraging its leadership in med-tech manufacturing and strategic acquisitions to outpace the market
(Extract from their Q2 letter) https://t.co/bDaYNMjoUj
tweet
Baron Capital on Integer Holdings Corporation $ITGR US
Thesis: Integer Holdings is primed for rapid growth, leveraging its leadership in med-tech manufacturing and strategic acquisitions to outpace the market
(Extract from their Q2 letter) https://t.co/bDaYNMjoUj
tweet
Offshore
Photo
Librarian Capital
FeverTree $FEVR: top-3 holders include Lindsell Train (#1, 15.4%) and Smithson (#3, 6.2%)
Smithson bought back in 2019; more recently they are known for selling Rightmove $RMV near the bottom (in late 2023, when they also bought Croda $CRDA)
Investing is simple but not easy https://t.co/OwSTEm2UGT
tweet
FeverTree $FEVR: top-3 holders include Lindsell Train (#1, 15.4%) and Smithson (#3, 6.2%)
Smithson bought back in 2019; more recently they are known for selling Rightmove $RMV near the bottom (in late 2023, when they also bought Croda $CRDA)
Investing is simple but not easy https://t.co/OwSTEm2UGT
FeverTree $FEVR discussion agenda
1/ Recap of thesis: FEVR as growth asset & acq. target
2/ Interpreting H1 sales growth; Jul-Aug acceleration
3/ Margin recovery & operational leverage
4/ FY24 outlook & FY25 comments
5/ Valuation and return forecasts
6/ Q&A
https://t.co/vHaevXLiq0 tweet
Offshore
Photo
Dimitry Nakhla | Babylon Capital®
RT @DimitryNakhla: A sober valuation analysis on $META 🧘🏽♂️
•NTM P/E Ratio: 22.65x
•10-Year Mean: 26.32x
•NTM FCF Yield: 3.60%
•10-Year Mean: 3.33%
As you can see, $META appears to be slightly undervalued
Going forward, investors can expect to receive ~16% MORE in earnings per share & ~8% MORE in FCF per share🧠***
Before we get into valuation, let’s take a look at why $META is a quality business
BALANCE SHEET✅
•Cash & Equivalents: $58.08B
•Long-Term Debt: $18.39B
$META has an excellent balance sheet, an AA- S&P Credit Rating & 148x FFO Interest Coverage Ratio
RETURN ON CAPITAL✅
•2019: 26.0%
•2020: 23.5%
•2021: 33.7%
•2022: 22.0%
•2023: 26.3%
•LTM: 31.7%
RETURN ON EQUITY✅
•2019: 20.0%
•2020: 25.4%
•2021: 31.1%
•2022: 18.5%
•2023: 28.0%
•LTM: 35.4%
$META has great return metrics, highlighting the financial efficiency of the business
REVENUES✅
•2018: $55.84B
•2023: $134.90B
•CAGR: 19.29%
FREE CASH FLOW✅
•2018: $15.36B
•2023: $43.85B
•CAGR: 23.34%
NORMALIZED EPS✅
•2018: $7.57
•2023: $14.87
•CAGR: 14.45%
SHARE BUYBACKS✅
•2018 Shares Outstanding: 2.92B
•LTM Shares Outstanding: 2.64B
By reducing its shares outstanding ~9.5%, $META increased its EPS by ~10.5% (assuming 0 growth)
MARGINS✅
•LTM Gross Margins: 81.5%
•LTM Operating Margins: 41.2%
•LTM Net Income Margins: 34.3%
***NOW TO VALUATION 🧠
As stated above, investors can expect to receive ~16% MORE in EPS & ~8% MORE in FCF per share
Using Benjamin Graham’s 2G rule of thumb, $META has to grow earnings at an 11.33% CAGR over the next several years to justify its valuation
Today, analysts anticipate 2024 - 2026 EPS growth over the next few years to be greater than the (11.33%) required growth rate:
2024E: $21.26 (43.0% YoY) *FY Dec
2025E: $24.41 (14.8% YoY)
2026E: $27.97 (14.6% YoY)
$META has a decent track record of meeting analyst estimates ~2 years out, so let’s assume $META ends 2026 with $27.97 in EPS & see its CAGR potential assuming different multiples
24x P/E: $671.28💵 … ~12.7% CAGR
23x P/E: $643.31💵 … ~10.7% CAGR
22x P/E: $615.34💵 … ~8.6% CAGR
21x P/E: $587.37💵 … ~6.5% CAGR
As you can see, $META appears to have double-digit CAGR potential if we assume >23x earnings, a multiple slightly below what it’s trading for today and a multiple below what may be justified given its mid-teens earnings growth rate
And as we’ve already seen, the increased investment in future growth and necessary AI development has the potential to drive better growth prospects could be a bullish catalyst for the next several years
Today at $511💵 $META appears to be a decent consideration for investment
$META appears to be an excellent deal closer to $465💵 where it has ~11% CAGR potential assuming 2026E and a 21x multiple (an added layer of margin of safety)
#stocks #investing
___
𝐃𝐈𝐒𝐂𝐋𝐎𝐒𝐔𝐑𝐄‼️: 𝐓𝐡𝐢𝐬 𝐢𝐬 𝐍𝐎𝐓 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐀𝐝𝐯𝐢𝐜𝐞. 𝐁𝐚𝐛𝐲𝐥𝐨𝐧 𝐂𝐚𝐩𝐢𝐭𝐚𝐥® 𝐚𝐧𝐝 𝐢𝐭𝐬 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐯𝐞𝐬 𝐦𝐚𝐲 𝐡𝐚𝐯𝐞 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐢𝐞𝐬 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭.
𝐓𝐡𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭 𝐢𝐬 𝐢𝐧𝐭𝐞𝐧𝐝𝐞𝐝 𝐟𝐨𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐩𝐮𝐫𝐩𝐨𝐬𝐞𝐬 𝐨𝐧𝐥𝐲 𝐚𝐧𝐝 𝐬𝐡𝐨𝐮𝐥𝐝 𝐧𝐨𝐭 𝐛𝐞 𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐞𝐝 𝐚𝐬 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐚𝐝𝐯𝐢𝐜𝐞 𝐭𝐨 𝐦𝐞𝐞𝐭 𝐭𝐡𝐞 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐧𝐞𝐞𝐝𝐬 𝐨𝐟 𝐚𝐧𝐲 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥 𝐨𝐫 𝐬𝐢𝐭𝐮𝐚𝐭𝐢𝐨𝐧. 𝐏𝐚𝐬𝐭 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐢𝐬 𝐧𝐨 𝐠𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞 𝐨𝐟 𝐟𝐮𝐭𝐮𝐫𝐞 𝐫𝐞𝐬𝐮𝐥𝐭𝐬.
𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐨𝐛𝐭𝐚𝐢𝐧𝐞𝐝 𝐟𝐫𝐨𝐦 𝐬𝐨𝐮𝐫𝐜𝐞𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐫𝐞𝐥𝐢𝐚𝐛𝐥𝐞, 𝐛𝐮𝐭 𝐢𝐬 𝐧𝐨𝐭 𝐠𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞𝐝 𝐚𝐬 𝐭𝐨 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐧𝐞𝐬𝐬 𝐨𝐫 𝐚𝐜𝐜𝐮𝐫𝐚𝐜𝐲.
tweet
RT @DimitryNakhla: A sober valuation analysis on $META 🧘🏽♂️
•NTM P/E Ratio: 22.65x
•10-Year Mean: 26.32x
•NTM FCF Yield: 3.60%
•10-Year Mean: 3.33%
As you can see, $META appears to be slightly undervalued
Going forward, investors can expect to receive ~16% MORE in earnings per share & ~8% MORE in FCF per share🧠***
Before we get into valuation, let’s take a look at why $META is a quality business
BALANCE SHEET✅
•Cash & Equivalents: $58.08B
•Long-Term Debt: $18.39B
$META has an excellent balance sheet, an AA- S&P Credit Rating & 148x FFO Interest Coverage Ratio
RETURN ON CAPITAL✅
•2019: 26.0%
•2020: 23.5%
•2021: 33.7%
•2022: 22.0%
•2023: 26.3%
•LTM: 31.7%
RETURN ON EQUITY✅
•2019: 20.0%
•2020: 25.4%
•2021: 31.1%
•2022: 18.5%
•2023: 28.0%
•LTM: 35.4%
$META has great return metrics, highlighting the financial efficiency of the business
REVENUES✅
•2018: $55.84B
•2023: $134.90B
•CAGR: 19.29%
FREE CASH FLOW✅
•2018: $15.36B
•2023: $43.85B
•CAGR: 23.34%
NORMALIZED EPS✅
•2018: $7.57
•2023: $14.87
•CAGR: 14.45%
SHARE BUYBACKS✅
•2018 Shares Outstanding: 2.92B
•LTM Shares Outstanding: 2.64B
By reducing its shares outstanding ~9.5%, $META increased its EPS by ~10.5% (assuming 0 growth)
MARGINS✅
•LTM Gross Margins: 81.5%
•LTM Operating Margins: 41.2%
•LTM Net Income Margins: 34.3%
***NOW TO VALUATION 🧠
As stated above, investors can expect to receive ~16% MORE in EPS & ~8% MORE in FCF per share
Using Benjamin Graham’s 2G rule of thumb, $META has to grow earnings at an 11.33% CAGR over the next several years to justify its valuation
Today, analysts anticipate 2024 - 2026 EPS growth over the next few years to be greater than the (11.33%) required growth rate:
2024E: $21.26 (43.0% YoY) *FY Dec
2025E: $24.41 (14.8% YoY)
2026E: $27.97 (14.6% YoY)
$META has a decent track record of meeting analyst estimates ~2 years out, so let’s assume $META ends 2026 with $27.97 in EPS & see its CAGR potential assuming different multiples
24x P/E: $671.28💵 … ~12.7% CAGR
23x P/E: $643.31💵 … ~10.7% CAGR
22x P/E: $615.34💵 … ~8.6% CAGR
21x P/E: $587.37💵 … ~6.5% CAGR
As you can see, $META appears to have double-digit CAGR potential if we assume >23x earnings, a multiple slightly below what it’s trading for today and a multiple below what may be justified given its mid-teens earnings growth rate
And as we’ve already seen, the increased investment in future growth and necessary AI development has the potential to drive better growth prospects could be a bullish catalyst for the next several years
Today at $511💵 $META appears to be a decent consideration for investment
$META appears to be an excellent deal closer to $465💵 where it has ~11% CAGR potential assuming 2026E and a 21x multiple (an added layer of margin of safety)
#stocks #investing
___
𝐃𝐈𝐒𝐂𝐋𝐎𝐒𝐔𝐑𝐄‼️: 𝐓𝐡𝐢𝐬 𝐢𝐬 𝐍𝐎𝐓 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐀𝐝𝐯𝐢𝐜𝐞. 𝐁𝐚𝐛𝐲𝐥𝐨𝐧 𝐂𝐚𝐩𝐢𝐭𝐚𝐥® 𝐚𝐧𝐝 𝐢𝐭𝐬 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐯𝐞𝐬 𝐦𝐚𝐲 𝐡𝐚𝐯𝐞 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐢𝐞𝐬 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭.
𝐓𝐡𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭 𝐢𝐬 𝐢𝐧𝐭𝐞𝐧𝐝𝐞𝐝 𝐟𝐨𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐩𝐮𝐫𝐩𝐨𝐬𝐞𝐬 𝐨𝐧𝐥𝐲 𝐚𝐧𝐝 𝐬𝐡𝐨𝐮𝐥𝐝 𝐧𝐨𝐭 𝐛𝐞 𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐞𝐝 𝐚𝐬 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐚𝐝𝐯𝐢𝐜𝐞 𝐭𝐨 𝐦𝐞𝐞𝐭 𝐭𝐡𝐞 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐧𝐞𝐞𝐝𝐬 𝐨𝐟 𝐚𝐧𝐲 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥 𝐨𝐫 𝐬𝐢𝐭𝐮𝐚𝐭𝐢𝐨𝐧. 𝐏𝐚𝐬𝐭 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐢𝐬 𝐧𝐨 𝐠𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞 𝐨𝐟 𝐟𝐮𝐭𝐮𝐫𝐞 𝐫𝐞𝐬𝐮𝐥𝐭𝐬.
𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐨𝐛𝐭𝐚𝐢𝐧𝐞𝐝 𝐟𝐫𝐨𝐦 𝐬𝐨𝐮𝐫𝐜𝐞𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐫𝐞𝐥𝐢𝐚𝐛𝐥𝐞, 𝐛𝐮𝐭 𝐢𝐬 𝐧𝐨𝐭 𝐠𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞𝐝 𝐚𝐬 𝐭𝐨 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞𝐧𝐞𝐬𝐬 𝐨𝐫 𝐚𝐜𝐜𝐮𝐫𝐚𝐜𝐲.
tweet
Offshore
Photo
Stock Analysis Compilation
Davis fund on Applied Materials $AMAT US
Thesis: Applied Materials is primed to benefit from the AI boom, leveraging its expertise in advanced semiconductor manufacturing to capture a growing market share
(Extract from their Q2 letter) https://t.co/gptVE7XIlM
tweet
Davis fund on Applied Materials $AMAT US
Thesis: Applied Materials is primed to benefit from the AI boom, leveraging its expertise in advanced semiconductor manufacturing to capture a growing market share
(Extract from their Q2 letter) https://t.co/gptVE7XIlM
tweet
Offshore
Photo
Librarian Capital
FeverTree $FEVR: Growth doesn't depend on Gin
Even in UK, home of "gin & tonic":
- 28% of FEVR sales from non-tonics in H1
- Non-tonic categories grew by ~10% y/y
- Ginger Ale, cocktail mixers, soft drinks all growing
- Fever-Tree is #1 flavored soda brand in Off Trade https://t.co/f8SfdJQA3H
tweet
FeverTree $FEVR: Growth doesn't depend on Gin
Even in UK, home of "gin & tonic":
- 28% of FEVR sales from non-tonics in H1
- Non-tonic categories grew by ~10% y/y
- Ginger Ale, cocktail mixers, soft drinks all growing
- Fever-Tree is #1 flavored soda brand in Off Trade https://t.co/f8SfdJQA3H
"FeverTree: H1 Showed Costs are On Track, Even if Growth is Not (Yet)"
$FEVR shares fell 12% after results and are lowest since 2016, but key parts of our thesis were validated.
https://t.co/uqjaYJE1qt https://t.co/KLbdWFjeUW tweet